Menú

USR Barcelona

RESPONSABLE
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Publicaciones

Value contribution of Etranacogene dezaparvovec for the treatment of severe and moderately severe haemophilia B in Spain through multicriteria decision analysis (MCDA)

D. DIEGO, V. JIMÉNEZ-YUSTE, R. VAZQUEZ, O. HIDALGO, J. POVEDA, J. GIMÉNEZ, J. TRILLO, J. VALLÈS, R. PÉREZ-SANTAMARINA and X. BADIA
HAEMOPHILIA. 2024 Apr 1;

Ver más:
Resistant Hypertension and Mortality: An Observational Cohort Study.

de la Sierra A, Ruilope LM, Staplin N, Gorostidi M, Vinyoles E, Segura J, Armario P, Oliveras A and Williams B
HYPERTENSION. 2024 Nov 1; . doi:10.1161/HYPERTENSIONAHA.124.23276; PMID:39247961

Ver más:
Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi-criteria decision analysis

D. GARCÍA-DIEGO, X. BADIA, O. BENÍTEZ-HIDALGO, V. JIMÉNEZ, J. JUÁREZ, R. NÚÑEZ, J. POVEDA, J. TRILLO and J. VALLÉS
HAEMOPHILIA. 2024 Sep 28; . doi:10.1111/hae.15096; PMID:39340327

Ver más:
First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.

Ortega E, Genua I, Mata-Cases M, Roqué M, Vlacho B, Real Gatius J, Franch-Nadal J and Mauricio D
Frontiers in Cardiovascular Medicine. 2024 Sep 17; . doi:10.3389/fcvm.2024.1403363; PMID:39355347

Ver más:
Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study.

Ramírez-Morros A, Berenguera A, Millaruelo L, Buil-Cosiales P, Gomez Garcia C, Cos X, Ávila Lachica L, Artola S, Millaruelo JM, Mauricio D and Franch-Nadal J
Patient Preference and Adherence. 2024 Sep 13; . doi:10.2147/PPA.S466931; PMID:39290823

Ver más:

Patronato

Colaboradores

Acreditaciones